(Reuters) - U.S. health regulators on Friday approved Abbott Laboratories Inc's blockbuster rheumatoid arthritis drug Humira for the treatment of moderate to severe ulcerative colitis, a form of inflammatory bowel disease.
via Reuters: Health News Read More Here..
No comments:
Post a Comment